Small Molecules
15 April 2015
Celprogen Introduces a Novel Pharmacological Inhibitor CEP1430 for Human Pancreatic Cancer Patients15 April 2015
FDA Advisory Committee Reviews Takeda’s Alogliptin EXAMINE Cardiovascular Safety Outcomes Trial14 April 2015
Hydra Biosciences Receives Approval from Health Canada to Begin Phase 1 Trial for HX-10010 April 2015
Eisai and Arena Pharmaceuticals Complete Registrational Trials of an Extended Release Formulation of Lorcaserin10 April 2015
Embera NeuroTherapeutics Secures A-2 Financing to Advance EMB-001 for Addictions Through Phase 1 Clinical Trial7 April 2015
Shire Announces Clear Regulatory Path Forward for SHP465, an Investigational Treatment for Adults with ADHD7 April 2015
Pharmaxis Releases Interim Results of Phase 1 Clinical Trial for SSAO / VAP-1 Inhibitor PXS4728ANews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports